Page 10 - Pharma eZine 140828

How can companies beneit from

improving access to medicines?

That’s why we need to help them perform beter.”
Wim Leereveld, Founder and CEO of the Access to “My inspiraion to set up the Access to Medicine
Medicine Foundaion, talks to RepRisk about the Index was to support the two billion people who Wim says the Index helps pharmaceuical companies

Access to Medicine Index.
have“no access to medicine to protect themselves to have greater awareness of what’s going on in the
against diseases such as tuberculosis, malaria and ield of access to medicine.

The concept that business is only in operaions for HIV/AIDS,” says Wim.
proit is a fable that has long since lost its luster. “It helps to deine their path in the world. Some

Ciizens around the world now hold drug companies companies do rather well and they have something In my view, the
to account over their willingness to provide access to ofer, something to show other companies. When ”
pharmaceuical industry
to medicine to the world’s poorest people.
that’s not seen, companies can’t learn from each
other. When there is a list, where you can see
is not the problem; they
Wim Leereveld, Founder and CEO of the Access to exactly how companies deal with this problem, in
Medicine Foundaion is one such ciizen.
pricing, in patents, in research and development, are part of the soluion.

then other companies can learn from this increased

In 2004, Wim established the Access to Medicine transparency.”
Foundaion in Amsterdam, with a core focus on “Having worked with the pharmaceuical industry

the role of the world’s leading pharmaceuical The Access to Medicine Index (ATMI) is an for more than 15 years, I knew these companies
companies in delivering access to medicine in low independent iniiaive that provides insight into were willing to do something about this, but they

and middle-income countries. The Netherlands- what the world’s leading pharmaceuical companies needed to receive credit for their eforts and help.
based non-proit organizaion aims to advance are doing for the millions of people in developing In my view the Pharmaceuical industry is not the

access to medicine in developing countries by countries who do not have reliable access to safe, problem; they are part of the soluion. They have
encouraging the pharmaceuical industry to accept efecive and afordable medicines, vaccines and the know-how to create potenially life saving

a greater role in improving access.
other health-related technologies.
drugs.

Everyday

RepRisk

is trusted by

the world’s

leading

Asset Managers,

Banks &

Multinationals

RepRisk ESG Business Intelligence Company Lite Reports

Updated daily - Available now on FactSet under “Embargoed Research”

10
INSIGHT